COMMUNIQUÉS West-GlobeNewswire

Nika Pharmaceuticals, Inc. (OTCQB: NIKA) June 2026 Update
04/06/2026
HENDERSON, Nev., June 04, 2026 (GLOBE NEWSWIRE) -- Nika Pharmaceuticals, Inc. (OTCQB: NIKA ) is currently engaged in active discussions with several investors from Europe and the US who have demonstrated significant [...]
NMDP Celebrates Milestone 150,000th Transplant Representing Nearly Four Decades of Hope, Innovation and Second Chances
04/06/2026
The landmark achievement reflects the collective impact of patients, donors, caregivers, researchers, volunteers, advocates, financial supporters and transplant partners advancing access to life-saving cell therapy [...]
Centre for Neuro Skills’ Chris Persel Receives First-Ever Enduring Contributions Award
04/06/2026
Applied Behavior Analysis International Brain Injury Special Interest Group Honors Four-Decade Career in Neurorehabilitation at 52nd Annual Conference BAKERSFIELD, Calif., June 04, 2026 (GLOBE NEWSWIRE) -- Centre for [...]
Adam Ferrari Health Science Scholarship Application Deadline Approaches for 2026 Cycle
04/06/2026
Students Pursuing Careers in Health Science Have Until June 30, 2026, to Apply for the $20,000 Scholarship IRVINE, Calif., June 04, 2026 (GLOBE NEWSWIRE) -- The 2026 Adam Ferrari Health Science Scholarship is accepting [...]
Oncovita presents promising preclinical data on MVdeltaC, a novel onco-immunotherapy at EACR, 8-11 June 2026, in Budapest
04/06/2026
The full preclinical pharmacology package includes results from many solid tumors models including mesothelioma, bladder, triple negative breast cancer (TNBC) and neuroblastoma and the demonstration of the mechanism of [...]
Nexalin Technology Announces Issuance of U.S. Patent Covering Dynamic Frequency Stimulation for Anxiety, Depression and Insomnia
04/06/2026
Newly issued U.S. patent expected to provide core intellectual property protection through 2042, further strengthening Nexalin’s proprietary position in non-invasive frequency-based deep-brain neurostimulation Patent [...]
Seven Arrows Recovery Expands Public Education Efforts Around Forward-Facing, Nervous System Centred Addiction Treatment
04/06/2026
The Arizona residential treatment center introduces broader awareness of its trauma-informed and salutogenic recovery model through Forward-Facing® Accelerated Recovery Elfrida, ARIZONA, June 04, 2026 (GLOBE NEWSWIRE [...]
Arvinas Joins The Michael J. Fox Foundation’s LITE and PPMI Programs to Advance New Therapies Targeting LRRK2 for Parkinson’s Disease
04/06/2026
NEW HAVEN, Conn., June 04, 2026 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a biotechnology company creating a new class of drugs based on targeted protein degradation, today announced it has recently joined the [...]
Fate Therapeutics Showcases Data from FT819 and FT839 Programs at the European Congress of Rheumatology Annual Meeting
04/06/2026
FT819 off-the-shelf CAR T-cell therapy product candidate continues to broaden patient access with 21 SLE patients now treated, including as outpatient administration in community hospitals Continued demonstration of [...]
Immutep to Present Positive Interim Phase I Data for IMP761, a First-in-Class LAG-3 Agonist Antibody, at EULAR 2026
04/06/2026
First-in-human Phase I study met its primary endpoint, demonstrating favourable safety and tolerability in healthy volunteers in the single ascending dose part of the study Phase I data demonstrate statistically [...]
Pure Harvest Corporate Group (OTC: PHCG), Operating as Mixie Technologies, Announces HoloTwin 2.0 Framework for Large-Scale 3D Visualization in the Browser
04/06/2026
With the coming HT Scan capture app, HoloTwin 2.0 forms an end-to-end platform for creating digital twins of buildings and campuses and sharing them across an organization in a standard web browser DENVER, June 04, 2026 [...]
IMUNON Announces Up to $10 Million Cash Financing
04/06/2026
Includes up-front issuance of preferred stock for $2.5 million and secured promissory notes for $7.72 million Uniquely structured, flexible financing supports IMUNON’s Highly Anticipated Phase 3 OVATION 3 Study of IMNN- [...]
Noom Members Kept Losing Weight a Full Year After the Program Ended, Largest-Ever Noom Randomized Clinical Trial Shows
04/06/2026
Peer-reviewed randomized controlled trial of 427 adults found that after completing Noom’s 16-week program, members continued losing weight for the next 52 weeks — reaching an average 4.1% body weight loss by week 68. [...]
Teva Expands European biosimilars portfolio with launch of AHZANTIVE® (aflibercept) biosimilar to Eylea®
04/06/2026
AHZANTIVE ® (aflibercept) is an EMA-approved biosimilar to Eylea ® (aflibercept) with demonstrated similarity in efficacy, safety and immunogenicity to the reference product The launch expands Teva’s biosimilars [...]
NXTC Announces Replay Available for Virtual KOL Event Discussing ASCO 2026 Dose Escalation Data from Phase 1 Trial of SIM0505 for Gynecologic Cancers
04/06/2026
BELTSVILLE, Md., June 04, 2026 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel therapies to treat cancer, today announced the [...]
Emergent BioSolutions Supports Victoria’s Voice Foundation’s National Naloxone Awareness Day to Help Save Lives from Opioid Overdose
04/06/2026
Efforts focus on increasing awareness, expanding access to lifesaving NARCAN® Nasal Spray and reaching more communities with educational initiatives and resources GAITHERSBURG, Md., June 04, 2026 (GLOBE NEWSWIRE) -- In [...]
Melanoma Research Alliance Appoints Stephanie Kauffman as Chief Executive Officer
04/06/2026
WASHINGTON, June 04, 2026 (GLOBE NEWSWIRE) -- The Melanoma Research Alliance (MRA), the world's leading nonprofit funder of melanoma research, today announced the appointment of Stephanie Kauffman as Chief Executive [...]
Daré Bioscience Announces the Upcoming Launch of Flora Sync LF5™ Vaginal Probiotic Capsules
04/06/2026
First Product Revenue Expected This Month, Opening New Commercial Chapter for Women's Health Innovator Limited-Time Launch Offer: 30% Off + Free Shipping SAN DIEGO, June 04, 2026 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc [...]
Oncotelic Therapeutics Inc. (OTCQB: OTLC) Eyeing Nanotech-Driven Delivery Systems, Pharmacokinetic Optimization to Advance Existing Oncology Therapies
04/06/2026
NEW YORK, June 04, 2026 (GLOBE NEWSWIRE) -- via BioMedWire -- Oncotelic Therapeutics Inc. (OTCQB: OTLC) today announces its placement in an editorial published by BioMedWire (BMW), one of 75+ brands within the Dynamic [...]

Pages